Cite

HARVARD Citation

    Tinker, A. et al. (n.d.). 2022-RA-1194-ESGO Efficacy of dostarlimab in endometrial cancer by molecular subtype: a post hoc analysis of the GARNET study. International journal of gynecological cancer. p. A413. [Online]. 
  
Back to record